{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:29:11Z","timestamp":1793730551979,"version":"4.6.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["NKI 2006-4176"],"award-info":[{"award-number":["NKI 2006-4176"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ejso.2019.05.006","type":"journal-article","created":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T01:37:46Z","timestamp":1557711466000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer"],"prefix":"10.1016","volume":"47","author":[{"given":"S.N.","family":"Koole","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Kieffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"K.Sikorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Schagen van Leeuwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.W.R.","family":"Schreuder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.H.","family":"Hermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.H.","family":"de Hingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.J.","family":"Arts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.P.C.","family":"van Ham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.G.","family":"Aalbers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.J.","family":"Verwaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.K.","family":"Van de Vijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.S.","family":"Sonke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.","family":"van Driel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.K.","family":"Aaronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2019.05.006_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejso.2019.05.006_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0959-8049(01)00350-1","article-title":"Estimates of cancer incidence and mortality in Europe in 1995","volume":"38","author":"Bray","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2019.05.006_bib3","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.ejso.2019.05.006_bib4","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","article-title":"The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma","volume":"170","author":"Hoskins","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejso.2019.05.006_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2019.05.006_bib6","series-title":"Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer","author":"Jaaback","year":"2016"},{"issue":"26","key":"10.1016\/j.ejso.2019.05.006_bib7","first-page":"2841","article-title":"Use and effectiveness of intraperitoneal chemotherapy for treatment of ovarian cancer","volume":"33","author":"Wright","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.05.006_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ygyno.2005.11.013","article-title":"Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a Gynecologic Oncology Group study","volume":"100","author":"Walker","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejso.2019.05.006_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/EDBK_158927","article-title":"Update on intraperitoneal chemotherapy for the treatment of epithelial ovarian cancer","volume":"35","author":"Gourley","year":"2016","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ejso.2019.05.006_bib10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ejso.2019.05.006_bib11","first-page":"59","article-title":"Quality of life research in cancer clinical trials: a need for common rules and language","volume":"4","author":"Aaronson","year":"1990","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.ejso.2019.05.006_bib12","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.ejso.2019.05.006_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jclinepi.2015.08.007","article-title":"Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust","volume":"69","author":"Giesinger","year":"2016","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.ejso.2019.05.006_bib14","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0959-8049(03)00307-1","article-title":"An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-OV28) in assessing the quality of life of patients with ovarian cancer","volume":"39","author":"Greimel","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2019.05.006_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0959-8049(98)00357-8","article-title":"The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life","volume":"35","author":"Sprangers","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2019.05.006_bib16","series-title":"EORTC QLQ-C30 scoring manual","author":"Fayers","year":"2001"},{"key":"10.1016\/j.ejso.2019.05.006_bib17","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/1097-0258(20000715)19:13<1793::AID-SIM482>3.0.CO;2-Q","article-title":"Modelling covariance structure in the analysis of repeated measures data","volume":"19","author":"Littell","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/j.ejso.2019.05.006_bib18","series-title":"Analysis of longitudinal data","first-page":"169","author":"Diggle","year":"2002"},{"key":"10.1016\/j.ejso.2019.05.006_bib19","series-title":"Rosnow, essentials of behavioral Research: methods and data analysis, New York","author":"Rosenthal","year":"2008"},{"key":"10.1016\/j.ejso.2019.05.006_bib20","series-title":"Statistical power analysis for the","author":"Cohen","year":"1988"},{"key":"10.1016\/j.ejso.2019.05.006_bib21","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"key":"10.1016\/j.ejso.2019.05.006_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1245\/s10434-012-2579-9","article-title":"Quality of life in patients after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is it worth the risk?","volume":"20","author":"Tsilimparis","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.05.006_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ejso.2013.11.019","article-title":"Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: a prospective study of 216 patients","volume":"40","author":"Passot","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2019.05.006_bib24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ejso.2013.12.028","article-title":"Quality of life in patients with peritoneal surface malignancies after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"40","author":"Chia","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2019.05.006_bib25","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1245\/s10434-013-3133-0","article-title":"Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: an Asian perspective","volume":"20","author":"Tan","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2019.05.006_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11136-015-1050-3","article-title":"Ostomy-related problems and their impact on quality of life of colorectal cancer ostomates: a systematic review","volume":"25","author":"Vonk-Klaassen","year":"2016","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ejso.2019.05.006_bib27","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/WON.0b013e3181f90f0c","article-title":"Concerns and quality of life before surgery and during the recovery period in patients with rectal cancer and an ostomy","volume":"37","author":"Carlsson","year":"2010","journal-title":"J\u00a0Wound, Ostomy Cont Nurs"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319304445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319304445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:38:13Z","timestamp":1762310293000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798319304445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0748798319304445"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.05.006","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}